問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
馮思中
下載
2016-11-01 - 2022-10-28
Condition/Disease
metastatic hormone-sensitive prostate cancer
Test Drug
BAY 1841788/ODM-201(Darlutamide)
Participate Sites8Sites
Recruiting6Sites
2024-01-01 - 2031-12-31
Prostate Cancer Metastatic
MK-5684
Participate Sites5Sites
Recruiting5Sites
2022-01-01 - 2025-12-31
Participate Sites2Sites
Recruiting2Sites
2022-01-01 - 2024-12-31
Metastatic Prostate Cancer
Ga-68 PSMA ligand
Participate Sites1Sites
Recruiting1Sites
2018-11-01 - 2022-05-31
2020-12-01 - 2022-03-22
Participate Sites4Sites
Recruiting4Sites
2021-04-01 - 2022-12-20
2021-04-01 - 2025-10-31
Metastatic Castration-Resistant Prostate Cancer
AMG 509
2021-11-01 - 2022-08-29
Participate Sites6Sites
2022-08-01 - 2026-08-31
Participate Sites7Sites
Recruiting7Sites
全部
